Literature DB >> 29794409

The Effects of Long-Term Dietary Therapy on Patients with Hypertriglyceridemia.

Mizuki Yamanaka1, Masae Sakuma1, Asami Matsushita1, Satomi Tanaka1, Yuri Yamamoto2, Toshihiko Asai2, Hidekazu Arai1.   

Abstract

AIM: This study aimed to evaluate the effect of diet on serum lipids and to assess the effectiveness of long-term dietary therapy for hypertriglyceridemia.
METHODS: Seventy-nine patients (34 males and 45 females) with hypertriglyceridemia were enrolled and underwent dietary counseling for 12 months based on the following three recommendations: (1) reduce carbohydrate intake, (2) increase n-3 polyunsaturated fatty acid (PUFA) intake, and (3) limit alcohol drinking. We examined the effect of dietary therapy for 6 months on serum triglyceride (TG) levels and also compared the effectiveness of dietary and combined drug therapies on preventing arteriosclerotic disease from 7 to 12 months.
RESULTS: We observed that serum TG levels of the patients receiving dietary counseling were decreased compared with baseline at 6 months. Body weight and serum TG levels were decreased, and serum high-density lipoprotein levels were increased in the dietary therapy alone group, whereas BW, body mass index, and abdominal circumference were decreased in the combined drug treatment group compared with baselines at 6 and 12 months. Furthermore, the dietary therapy alone group demonstrated reductions in intake of total energy, carbohydrate, and saturated fatty acids, as well as n-6/n-3 PUFA ratio compared with baselines, but only n-6/n-3 PUFA ratio was decreased in the combined drug treatment group.
CONCLUSION: This study demonstrated a decrease in serum TG level after 12 months of dietary therapy similar to drug therapy, which suggests that it is an effective treatment for hypertriglyceridemia, and heightened awareness should be made to encourage its use.The clinical trial registration number: UMIN000028860.

Entities:  

Keywords:  Dietary therapy; Guidelines; Hypertriglyceridemia; Polyunsaturated fatty acid (PUFA)

Mesh:

Substances:

Year:  2018        PMID: 29794409      PMCID: PMC6308261          DOI: 10.5551/jat.42440

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  2 in total

1.  Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study.

Authors:  Shuo Pang; Guangrui Miao; Yuanhang Zhou; Yang Du; Ziao Rui; Xiaoyan Zhao
Journal:  Front Cardiovasc Med       Date:  2022-08-25

2.  Effect of intermittent versus continuous calorie restriction on body weight and cardiometabolic risk markers in subjects with overweight or obesity and mild-to-moderate hypertriglyceridemia: a randomized trial.

Authors:  Mahsa Maroofi; Javad Nasrollahzadeh
Journal:  Lipids Health Dis       Date:  2020-10-07       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.